13
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases

      review-article
      1 , 2 , 3 , 4 , 5 , 6 , 7 , , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 26 , 26 , 27 , 28 , 29 , 1 , 2 , 3 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 6 , 44 , 45
      Clinical and Translational Allergy
      BioMed Central
      Air pollution, Asthma, Chronic respiratory diseases, Guidelines, Integrated care pathways, mHealth, Rhinitis, Vilnius Declaration

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Over 1 billion people suffer from chronic respiratory diseases such as asthma, COPD, rhinitis and rhinosinusitis. They cause an enormous burden and are considered as major non-communicable diseases. Many patients are still uncontrolled and the cost of inaction is unacceptable. A meeting was held in Vilnius, Lithuania (March 23, 2018) under the patronage of the Ministry of Health and several scientific societies to propose multisectoral care pathways embedding guided self-management, mHealth and air pollution in selected chronic respiratory diseases (rhinitis, chronic rhinosinusitis, asthma and COPD). The meeting resulted in the Vilnius Declaration that was developed by the participants of the EU Summit on chronic respiratory diseases under the leadership of Euforea.

          Conclusion

          The Vilnius Declaration represents an important step for the fight against air pollution in chronic respiratory diseases globally and has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge.

          Related collections

          Most cited references57

          • Record: found
          • Abstract: found
          • Article: not found

          Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision.

          Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lost work productivity are even larger than those incurred by asthma. New evidence has accumulated since the last revision of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines in 2010, prompting its update.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A 10 year asthma programme in Finland: major change for the better.

              A National Asthma Programme was undertaken in Finland from 1994 to 2004 to improve asthma care and prevent an increase in costs. The main goal was to lessen the burden of asthma to individuals and society. The action programme focused on implementation of new knowledge, especially for primary care. The main premise underpinning the campaign was that asthma is an inflammatory disease and requires anti-inflammatory treatment from the outset. The key for implementation was an effective network of asthma-responsible professionals and development of a post hoc evaluation strategy. In 1997 Finnish pharmacies were included in the Pharmacy Programme and in 2002 a Childhood Asthma mini-Programme was launched. The incidence of asthma is still increasing, but the burden of asthma has decreased considerably. The number of hospital days has fallen by 54% from 110 000 in 1993 to 51 000 in 2003, 69% in relation to the number of asthmatics (n = 135 363 and 207 757, respectively), with the trend still downwards. In 1993, 7212 patients of working age (9% of 80 133 asthmatics) received a disability pension from the Social Insurance Institution compared with 1741 in 2003 (1.5% of 116 067 asthmatics). The absolute decrease was 76%, and 83% in relation to the number of asthmatics. The increase in the cost of asthma (compensation for disability, drugs, hospital care, and outpatient doctor visits) ended: in 1993 the costs were 218 million euro which had fallen to 213.5 million euro in 2003. Costs per patient per year have decreased 36% (from 1611 euro to 1031 euro). It is possible to reduce the morbidity of asthma and its impact on individuals as well as on society. Improvements would have taken place without the programme, but not of this magnitude.
                Bookmark

                Author and article information

                Contributors
                +33 611 42 88 47 , jean.bousquet@orange.fr
                Journal
                Clin Transl Allergy
                Clin Transl Allergy
                Clinical and Translational Allergy
                BioMed Central (London )
                2045-7022
                28 January 2019
                28 January 2019
                2019
                : 9
                : 7
                Affiliations
                [1 ]ISNI 0000 0001 2243 2806, GRID grid.6441.7, Department of Public Health, Clinic of Children’s Diseases, and Institute of Health Sciences, , Vilnius University Institute of Clinical Medicine, ; Vilnius, Lithuania
                [2 ]European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium
                [3 ]ISNI 0000 0000 9961 060X, GRID grid.157868.5, MACVIA-France, Fondation partenariale FMC VIA-LR, CHU Montpellier, ; 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France
                [4 ]INSERM U 1168, VIMA : Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France
                [5 ]ISNI 0000 0001 2323 0229, GRID grid.12832.3a, UMR-S 1168, , Université Versailles St-Quentin-en-Yvelines, ; Montigny le Bretonneux, France
                [6 ]Euforea, Brussels, Belgium
                [7 ]ISNI 0000 0001 2218 4662, GRID grid.6363.0, Charité, ; Berlin, Germany
                [8 ]Minister of Health, Vilnius, Lithuania
                [9 ]Minister of Health, Kiev, Ukraine
                [10 ]Minister of Labour, Health and Social Affairs, Tbilisi, Georgia
                [11 ]Minister of Health, Labour and Social Protection, Chișinău, Moldova
                [12 ]European Parliament, Perugia, Italy
                [13 ]European Parliament, Helsinki, Finland
                [14 ]Lithuianian Academy of Sciences, Vilnius, Lithuania
                [15 ]ISNI 0000 0001 2159 8361, GRID grid.5120.6, Faculty of Medicine, , Transylvania University, ; Brasov, Romania
                [16 ]Global Alliance Against Chronic Respiratory Diseases (GARD), Joensuu, Finland
                [17 ]GRID grid.439338.6, Imperial College and Royal Brompton Hospital, ; London, UK
                [18 ]ISNI 0000 0004 0428 8304, GRID grid.412274.6, Department of Pediatrics, and Iashvili Central Children’s Hospital, , Tbilisi State Medical University, ; Tbilisi, Georgia
                [19 ]ISNI 0000 0004 0563 0685, GRID grid.411517.7, Faculty of Postgraduate Education, , Lviv National Medical University by Danylo Halytsky, ; Lviv, Ukraine
                [20 ]ISNI 0000000404654431, GRID grid.5650.6, Department of Otorhinolaryngology, , Amsterdam University Medical Centres, AMC, ; Amsterdam, The Netherlands
                [21 ]ISNI 0000 0001 2171 1133, GRID grid.4868.2, Centre for Genomics and Child Health, Blizard Institute, , Queen Mary University of London, ; London, UK
                [22 ]ISNI 0000 0000 9950 5666, GRID grid.15485.3d, Skin and Allergy Hospital, , Helsinki University Hospital and University of Helsinki, ; Helsinki, Finland
                [23 ]ISNI 0000 0001 0943 7661, GRID grid.10939.32, Children’s Clinic, , Tartu University Institute of Clinical Medicine, ; Tartu, Estonia
                [24 ]Vinnytsa National Medical University by Mykola Pyrogov, Vinnytsa, Ukraine
                [25 ]Global Alliance Against Chronic Respiratory Diseases (GARD-WHO), Geneva, Switzerland
                [26 ]GRID grid.434606.3, European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), ; Brussels, Belgium
                [27 ]ISNI 0000 0001 2243 2806, GRID grid.6441.7, Department of Human and Medical Genetics, Institute of Biomedical Sciences, , Vilnius University Faculty of Medicine, ; Vilnius, Lithuania
                [28 ]Association of Medical Schools in Europe, Berlin, Germany
                [29 ]State Institute of Phtysiopulmonology by Chiril Draganiuk, Chisinau, Moldova
                [30 ]iQ4U Consultants Ltd, London, UK
                [31 ]ISNI 0000 0001 0831 3165, GRID grid.419019.4, Department of Genetics and Clinical Immunology, , National Institute of Tuberculosis and Lung Diseases, ; Warsaw, Poland
                [32 ]ISNI 0000 0001 2243 2806, GRID grid.6441.7, Clinic of Chest Diseases, Immunology and Allergology, Centre of Pulmonology and Allergology, Institute of Clinical Medicine, , Vilnius University Medical Faculty, ; Vilnius, Lithuania
                [33 ]GRID grid.440838.3, Medical School, , European University of Cyprus, ; Nicosia, Cyprus
                [34 ]ISNI 0000 0001 2034 6082, GRID grid.26193.3f, Tbilisi State University Faculty of Medicine, ; Tbilisi, Georgia
                [35 ]ISNI 0000 0001 2243 2806, GRID grid.6441.7, Clinic of Infectious Chest Diseases, Dermatology and Allergology, Institute of Biomedical Sciences, Institute of Clinical Medicine, , Vilnius University Faculty of Medicine, ; Vilnius, Lithuania
                [36 ]ISNI 0000 0001 2243 2806, GRID grid.6441.7, Clinic of ENT and Eye Diseases, Institute of Clinical Medicine, , Vilnius University Medical Faculty, ; Vilnius, Lithuania
                [37 ]Danish Commitee for Health Education, Copenhagen East, Denmark
                [38 ]ISNI 0000000113287408, GRID grid.13339.3b, Department of Prevention of Envinronmental Hazards and Allergology, , Medical University of Warsaw, ; Warsaw, Poland
                [39 ]ISNI 0000 0004 0418 5743, GRID grid.427559.8, Institute of Child and Adolescent Health at Arabkir Medical Centre, , Yerevan State Medical University, ; Yerevan, Armenia
                [40 ]ISNI 0000 0004 0432 6841, GRID grid.45083.3a, Department of Immunology and Allergology, Medical Academy, , Lithuanian University of Health Sciences, ; Kaunas, Lithuania
                [41 ]European Health Futures Forum (EHFF), Dromahair, Ireland
                [42 ]ISNI 0000 0004 0432 6841, GRID grid.45083.3a, Clinic of Children’s Diseases, Medical Academy, , Lithuanian University of Health Sciences, ; Kaunas, Lithuania
                [43 ]ISNI 0000 0001 2243 2806, GRID grid.6441.7, Department of Rehabilitation, Physical and Sports Medicine, Institute of Health Sciences, , Vilnius University Medical Faculty, ; Vilnius, Lithuania
                [44 ]ISNI 0000 0004 0626 3338, GRID grid.410569.f, Department of Otorhinolaryngology, , University Hospital Leuven, ; Leuven, Belgium
                [45 ]ISNI 0000000084992262, GRID grid.7177.6, Academic Medical Center, , University of Amsterdam, ; Amsterdam, The Netherlands
                Article
                242
                10.1186/s13601-019-0242-2
                6348633
                30705747
                6ebefa9b-3fea-4754-97c1-e02386cac4ba
                © The Author(s) 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 8 October 2018
                : 4 January 2019
                Categories
                Review
                Custom metadata
                © The Author(s) 2019

                Immunology
                air pollution,asthma,chronic respiratory diseases,guidelines,integrated care pathways,mhealth,rhinitis,vilnius declaration

                Comments

                Comment on this article